The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
AACR 2022 | Changing surgical approaches in lung cancer therapy
In this video, David Paul Carbone, MD, PhD, Ohio State University Comprehensive Cancer Center, Columbus, OH, reflects on advances in surgical approaches to lung cancer therapy. The introduction of robotically mediated and less invasive manual techniques has already led to improvements in patient outcomes, reduced hospitalization, and better maintained quality of life for this cohort. This interview was recorded at the American Association for Cancer Research (AACR) Annual Meeting 2022, New Orleans, LA.
